Nippon Shinyaku Co.,Ltd.
4516・Prime Market・Pharmaceuticals
Governance
Company with a Board of Corporate Auditors (12 directors, 4 of whom are outside directors; 4 corporate auditors, 2 of whom are outside auditors). A Nomination Committee and a Compensation Committee have been established under the Board of Directors, with a majority of each committee comprised of independent outside directors, and the chair of each committee is also an independent outside director. During the fiscal year under review, the Board of Directors met 14 times, with an attendance rate of 100% for all directors.
Risk Management
Based on the
Shareholder Returns
Policy is to maintain stable dividends while taking DOE into account. For FY2026 (ending March 2026), interim and year-end dividends are ¥62 each, totaling ¥124 per year (total dividends of ¥8,357 million, payout ratio of 28.1%). FY2027 (ending March 2027) is also planned at the same annual amount of ¥124. Share buybacks are effectively zero.
Dividend Policy
Under the basic policy of aiming to maximize corporate value, the policy is to maintain stable dividends while taking DOE (dividend on equity ratio) into account. Dividends are paid twice a year (interim and year-end). For FY2026 (ending March 2026), the actual annual dividend per share was ¥124 (interim ¥62 + year-end ¥62), total dividends were ¥8,357 million, the payout ratio was 28.1%, and the dividend ratio to equity attributable to owners of the parent was 3.1%. For FY2027 (ending March 2027), the forecast annual dividend per share is also ¥124 (interim ¥62 + year-end ¥62), with a forecast payout ratio of 27.6%.
ESG
The company supports the TCFD recommendations and has conducted 1.5°C and 4°C scenario analyses. It has set an SBTi-certified target of a 42% reduction in Scope 1+2 emissions by FY2030 (versus FY2020), with FY2024 results showing a 20.4% reduction and a 48% renewable energy adoption rate. In terms of human capital, the ratio of female managers stands at 15.5% (with a target of 17% by FY2028), the male childcare leave uptake rate is 75%, and the company was newly selected as a Health & Productivity Stock 2026. It is also advancing human rights due diligence, and has established a structure in which the Sustainability Committee (meeting twice a year) reports to the Board of Directors.
Last updated: June 23, 2026